Developing a risk score to inform the use of rhBMP-2 in adult spinal deformity surgery
Spine Deformity · 2025
DOI: 10.1007/s43390-024-00946-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spine Deformity, 2025. Verfasst von Tyler K Williamson und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Pseudarthrosis, Spinal Fusion, Transforming Growth Factor beta. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Recombinant human bone morphogenetic protein-2 (rhBMP-2) has not shown superior benefit overall in cost-effectiveness during adult spinal deformity (ASD) surgery. STUDY DESIGN/SETTING: Retrospective PURPOSE: Generate a risk score for pseudarthrosis to inform the utilization of rhBMP-2, balancing costs against quality of life and complications. METHODS: ASD patients with 3-year data were included. Quality of life gained was calculated from ODI to SF-6D and translated to quality-adjusted life years (QALYs). Cost was calculated using the PearlDiver database and CMS definitions for complications and comorbidities. Established weights were generated for predictive variables via logistic regression to yield a predictive risk score for pseudarthrosis that accounted for frailty, diabetes, depression, ASA grade, thoracolumbar kyphosis and three-column osteotomy use. Risk score categories, established via conditional inference tree (CIT)-derived thresholds were tested for cost-utility of rhBMP-2 usage, controlling for age, prior fusion, and baseline deformity and disability. RESULTS: 64% of ASD patients received rhBMP-2 (308/481). There were 17 (3.5%) patients that developed pseudarthrosis. rhBMP-2 use overall did not lower pseudarthrosis rates (OR: 0.5, [0.2-1.3]). Pseudarthrosis rates for each risk category were: No Risk (NoR) 0%; Low-Risk (LowR) 1.6%; Moderate Risk (ModR) 9.3%; High-Risk (HighR) 24.3%. Patients receiving rhBMP-2 had similar QALYs overall to those that did not (0.163 vs. 0.171, p = .65). rhBMP-2 usage had worse cost-utility in the LowR cohort (p < .001). In ModR patients, rhBMP-2 usage had equivocal cost-utility ($53,398 vs. $61,581, p = .232). In the HighR cohort, the cost-utility was reduced via rhBMP-2 usage ($98,328 vs. $211,091, p < .001). CONCLUSION: Our study shows rhBMP-2 demonstrates effective cost-utility for individuals at high risk for developing pseudarthrosis. The generated score can aid spine surgeons in the assessment of risk and enhance justification for the strategic use of rhBMP-2 in the appropriate clinical contexts. LEVEL OF EVIDENCE: III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA.
- Department of Orthopaedic Surgery, University of Texas Health San Antonio, San Antonio, TX, USA.
- Department of Orthopaedic Surgery, Brigham and Women's Hospital/Harvard Medical Center, Boston, MA, USA.
- Department of Orthopaedic Surgery, NYU Langone Medical Center, New York, NY, USA.
- Department of Orthopaedic Surgery, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
- Department of Orthopaedics, Lenox Hill Hospital, Northwell Health, New York, NY, USA.
ORCID-Profile: Peter G Passias
Zitieren
APA
Williamson, T. K., Onafowokan, O. O., Schoenfeld, A. J., Robertson, D., Owusu-Sarpong, S., Lebovic, J., Yung, A., Fisher, M. R., Cottrill, E. J., Diebo, B. G., Lafage, R., Lafage, V., Crutcher, C. L., Daniels, A. H., & Passias, P. G. (2025). Developing a risk score to inform the use of rhBMP-2 in adult spinal deformity surgery. Spine Deformity. https://doi.org/10.1007/s43390-024-00946-4
Vancouver
Williamson TK, Onafowokan OO, Schoenfeld AJ, Robertson D, Owusu-Sarpong S, Lebovic J, et al. Developing a risk score to inform the use of rhBMP-2 in adult spinal deformity surgery. Spine Deformity. 2025. doi:10.1007/s43390-024-00946-4
BibTeX
@article{Williamson2025,
author = {Williamson, Tyler K and Onafowokan, Oluwatobi O and Schoenfeld, Andrew J and Robertson, Djani and Owusu-Sarpong, Stephane and Lebovic, Jordan and Yung, Anthony and Fisher, Max R and Cottrill, Ethan J and Diebo, Bassel G and Lafage, Renaud and Lafage, Virginie and Crutcher, Clifford L and Daniels, Alan H and Passias, Peter G},
title = {Developing a risk score to inform the use of rhBMP-2 in adult spinal deformity surgery},
journal = {Spine Deformity},
year = {2025},
doi = {10.1007/s43390-024-00946-4}
}
EUVIMED